Search form


Press Releases

Axcan Pharma Announces Details for its Annual General Meeting

Jan 19, 2004 - 12:00 ET

Axcan Pharma Announces Details for its Annual General Meeting

MONT SAINT-HILAIRE, Quebec--Axcan Pharma Inc. ("Axcan" or the "Company") announced
today that it will host its fiscal 2003 Annual General Meeting on Thursday, February 19, 2004.
The Annual General Meeting, to conduct formal business, including the election of directors
and the appointment of auditors, will be held at the Omni Hotel in Montreal at 9:00 A.M. (ET).
For those who are unable to attend in person, a webcast of the meeting and management
presentation will be available on the Company's website at starting
February 20, 2004.

Axcan shareholders of record at the close of business on January 12, 2004, will receive
notice of the Annual General Meeting and will be entitled to vote upon matters considered
at the meeting. The Notice of Annual Meeting of Shareholders, the Management Proxy Circular,
and the Annual Report for fiscal 2003 will be sent to Axcan's shareholders on or about
January 22, 2004.

Shareholders are urged to read the proxy statement when it becomes available.

Axcan is a leading specialty pharmaceutical company involved in the field of
gastroenterology. The Company markets a broad line of prescription products sold for the
treatment of symptoms in a number of gastrointestinal diseases and disorders such as inflammatory
bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related
to cystic fibrosis. Axcan's products are marketed by its own sales force in North America and
Europe. Its common shares are listed on the Toronto Stock Exchange under the symbol "AXP" and on
the NASDAQ National Market under the symbol "AXCA".

INFORMATION:     David W. Mims
                 Executive Vice President and Chief Operating Officer
                 Axcan Pharma Inc.
                 Tel: (205) 991-8085 ext. 223

or               Isabelle Adjahi
                 Director, Investor Relations					
                 Axcan Pharma Inc.
                 Tel: (450) 467-2600 ext. 2000